| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $257.2M | +21.9% |
| Cost of Revenue | $159.0M | +126.9% |
| R&D Expense | $109.4M | -45.1% |
| SG&A Expense | $192.0M | -3.3% |
| Operating Income | -$203.2M | +20.9% |
| Interest Expense | $40.5M | +24.8% |
| Pre-tax Income | -$238.3M | +18.3% |
| Income Tax | -$380K | — |
| Net Income | -$237.9M |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $102.9M | +61.9% |
| Short-term Investments | $14.9M | -88.4% |
| Accounts Receivable | $260.5M | +136.9% |
| Inventory | $62.6M | +61.4% |
| Current Assets | $475.6M | +24.8% |
| Total Assets | $629.6M | +30.9% |
| Current Liabilities | $331.8M | +139.2% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$174.9M | +27.5% |
| Capital Expenditures | $286K | -86.0% |
| Investing Cash Flow | $144.6M | +186.7% |
| Financing Cash Flow | $69.6M | +28.1% |
| Free Cash Flow | -$175.2M | +28.0% |
| +18.5% |
| EPS (Basic) | -$2.53 | +32.7% |
| EPS (Diluted) | -$2.53 | +32.7% |
| Total Liabilities |
| $823.0M |
| +33.1% |
| Stockholders' Equity | -$193.4M | -40.8% |